Most people know that smoking is bad for the heart. It is also a well-known risk factor for atrial fibrillation. Much less is known, however, about the long-term effects of secondhand smoke.
As Afib research advances, it has become clear that not only genetics, but also lifestyle and environmental factors play important roles in shaping risk. Diet, physical activity, air quality, and what we are exposed to at home all matter. New research suggests that exposure to secondhand smoke—especially early in life—may increase the risk of developing Afib later on. Understanding this connection adds another important piece to the puzzle of why Afib develops.
What is secondhand smoke?
Secondhand smoke is the smoke that comes from a burning cigarette, cigar, or pipe, as well as the smoke exhaled by someone who is smoking. People nearby breathe it in, even if they don’t smoke themselves. This smoke contains thousands of chemicals, many of which are toxic or cancer-causing.
Unlike active smoking, secondhand exposure is usually involuntary. It happens in shared spaces such as homes, workplaces, cars, or public places.
Long-term exposure to secondhand smoke has been linked to many health problems, including breathing issues, heart disease, and cancer, as shown in large research reviews. Earlier studies have already shown that poor air quality and fine particulate pollution are linked to higher rates of Afib and stroke. More recent studies suggest that secondhand smoke is also harmful for cardiovascular health.
How nicotine affects heart rhythm
Exposure to nicotine, flavor chemicals, and fine particles from cigarettes or e‑cigarettes can interfere with the heart’s electrical system and increase the risk of Afib. Nicotine activates the sympathetic nervous system, often described as the body’s “fight or flight” system. It Over time, repeated exposure can lead to structural changes in the heart, such as scarring (atrial fibrosis), which makes the atria more likely to develop abnormal rhythms. Even secondhand smoke or aerosol from e‑cigarettes can contribute to these risks.
In recent years, especially among younger people, e‑cigarettes have been perceived as less harmful than regular cigarettes. However, they can still promote irregular heart rhythms in similar ways. New data also emphasizes that e‑cigarettes can harm not only the user but also the people around them.
Early-life exposure and its effect on Afib
New findings from the Health eHeart Study suggest that exposure to secondhand smoke before birth and during childhood may increase the risk of Afib later in life.
The study included nearly 5,000 adults who answered detailed questions about secondhand smoke exposure and their medical history. Around 12% reported having Afib. After adjusting for age, sex, and common cardiovascular risk factors, two early-life exposures remained clearly linked to Afib:
-
A mother smoking during pregnancy
-
Living with a smoker during childhood
-
These were associated with 37% and 40% higher odds of Afib, respectively.
The link was strongest in people without traditional risk factors such as high blood pressure, diabetes, or structural heart disease. This suggests that secondhand smoke in early life may leave lasting changes that increase Afib risk well into adulthood.
Can secondhand smoke exposure in adulthood increase Afib risk?
A large nationwide cohort study using UK Biobank data looked at the relationship between secondhand smoke and Afib in adults. Among more than 23,000 new Afib cases over 12.5 years, secondhand smoke exposure was linked to a modest but significant increase in risk, which grew with higher levels of exposure. This pattern was consistent whether the exposure occurred at home, at work, or outdoors.
Importantly, people who were both exposed to secondhand smoke and had a high genetic risk for Afib were at especially high risk. This suggests that avoiding secondhand smoke is particularly important for those who are genetically prone to Afib.
Another population-based case-control study of Israeli women who had never smoked found a strong link between secondhand smoke and Afib. Women exposed to secondhand smoke had nearly four times the risk of Afib compared with those never exposed. The risk rose with both the intensity and the timing of exposure:
-
Women exposed during more than one life stage (childhood, adolescence, adulthood) had a stepwise increase in risk.
-
The highest risk—over nine times that of never-exposed women—was seen in those exposed during all three periods.
-
Greater intensity of exposure, such as living with people who smoked about one pack a day, also significantly raised risk.
These results suggest that early and lifelong exposure to secondhand smoke has a strong effect on Afib development, at least in women.
The studies together show that secondhand smoke is not just an annoyance—it may be a meaningful risk factor for heart rhythm disorders. Because secondhand smoke exposure is preventable, these findings support the need for smoke-free environments, especially to protect children.
How MyAfib can help
Secondhand smoke and vaping exposure are risk factors you can actually track and potentially reduce. If you're managing Afib, understanding how environmental exposures affect your symptoms is an important part of your care strategy.
MyAfib is designed specifically for this purpose. As a dedicated Afib tracker, MyAfib allows you to log symptoms, heart rhythm readings, medications, and lifestyle factors in one place. By using MyAfib regularly to record habits alongside your symptoms, you create a clear picture of how your environment affects your heart rhythm. This structured record makes it easy to share with your healthcare provider during appointments.
If you notice that secondhand smoke is triggering your Afib episodes, having detailed records in MyAfib gives you concrete evidence to discuss practical prevention strategies with your care team. Whether it's avoiding certain environments, spending less time in smoky spaces, or having conversations with people in your home about indoor vaping, your MyAfib data supports more informed decisions about managing this controllable risk factor.
